Stay up to date on
research and information

Newsletter Signup

Donate to our Giving Tuesday Campaign and your gift will be matched through the Matching Gift Challenge!

Don’t miss FORCE’s 14th Annual Conference live In Philadelphia June 13-15, 2024.

Designed for anyone affected by hereditary cancer, this conference will educate and inspire you.

Find a healthcare expert or service.

Use our search tools or request help from a trained volunteer.

Meet Our Community

Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!

XRAY: Behind the News

Summaries of new cancer research and how it affects care.

Get Support

Learn about the many support options FORCE provides individuals and families.

Enroll in Research

Use our Search and Enroll Tool to find research studies enrolling people like you.

Get Updates

Receive hereditary cancer information and support delivered to your inbox.

Top Blog Posts

De Madres a Hijas: Educating Latina Mothers and Daughters about HBOC Risk

by Laura A. Logie, PhD Nueva Vida (New Life) is a community-based, non-profit organization providing culturally sensitive and competent cancer care services that support the Latino immigrant community. We work tirelessly to tackle the myriad of...

Embracing Hope and Unity: The Successful Introduction of Pink Ribbon Moms to Our Community

I am overwhelmed with gratitude as I sit to write this blog, reflecting on our recent community event, which was a resounding success. Our vision for Pink Ribbon Moms has always been to provide unwavering support to mothers who have experienced the...

Reflections on 10 Years Without Gene Patents

by Lisa Schlager, Vice President, Public Policy June 13, 2023 - On this date 10 years ago, I stood on the steps of the U.S. Supreme Court (SCOTUS) along with other advocates awaiting the ruling on the Association for Molecular Pathology...

See Full Blog